Integrating GPRC5D-Targeting Bispecifics for Relapsed/Refractory MM


Beth Faiman, PhD, MSN, explores how a GPRC5D-targeting bispecific antibody can benefit patients with relapsed/refractory multiple myeloma.

Recent Videos
Andrea Wagner, M.S.N., RN, OCN, in an interview with Oncology Nursing News discussing her abstract on verbal orders for CRS.
Related Content
© 2024 MJH Life Sciences

All rights reserved.